alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.1



 Exhibit 10.1 
 



 
 December 23, 2011 
 Mr. David J. McIntryre 
 3734 E Coquina Way 

Weston, FL 33332 USA 
 Dear David: 

This letter supplements and amends your letter of employment dated December 16, 2009, as amended. 

Effective December 30, 2011 (the “Reassignment Date”) and continuing through December 31, 2012, your role and responsibilities within
the HeartWare Group shall transition from Executive Vice President, Chief Financial Officer & Chief Operating Officer employed on a full-time basis by HeartWare, Inc. to Special Assistant to the Chief Executive Officer employed on a
part-time basis by HeartWare Pty Limited. Your responsibilities as Special Assistant shall include: overseeing the transfer of the Australian machining operation to new facility in Australia; overseeing the transfer of product distribution in
Australia and regional geographies to a sustainable location and the hiring of personnel to supervise distribution in a new facility; interfacing with the Australian Stock Exchange and investors as needed at the direction of the Chief Executive
Officer, General Counsel or Vice President, Investor Relations; providing ongoing assistance and advice to Operations personnel until a Vice President, Operations is hired and thereafter as needed; and acting as a consultant and adviser to the Chief
Executive Officer on operational, financial and strategic matters. 
 With effect as of the Reassignment Date, your base salary shall be at the
annual rate of AUD 50,000. Except as may be recommended by the Chief Executive Officer and approved by the Board of Directors of HeartWare International, Inc., you shall not be eligible for a merit, bonus or equity award for 2012. Your 2011 bonus
and accrued HeartWare, Inc. vacation time shall be paid on or prior to the Reassignment Date. 







 



 
 Please note that HeartWare does not presently provide health and similar benefits to employees of HeartWare Pty
Limited and therefore, consistent with Section 4 of your employment letter, we do not expect to provide you with health and similar benefits following the Reassignment Date. In addition, the Reassignment Date shall be treated as the trigger
date for purposes of the relocation benefits contemplated by Section 5 of your employment letter. However, as of the Reassignment Date, you shall no longer be a Section 16 Reporting Officer of HeartWare or eligible for Severance Pay as
contemplated by Section 6 of your employment letter. Except as set forth in this letter, the remaining provisions of your employment letter, as amended, shall remain in full force and effect. 

Please acknowledge your agreement with this letter by signing where indicated below. 
 Thank you again for your years of distinguished service to HeartWare. 
 With highest regards,

 /s/    Lawrence Knopf 
 Lawrence Knopf 
 Senior Vice President 
 And General Counsel 
  
 Agreed
and Acknowledged 
 This 26th day of December, 2011 

	
	
	/s/    David J. McIntyre         
	David J. McIntyre
| (logo) ncb  National Cooperative Bank    | 2011 Crystal Drive  Suite, 8oo  Arlington, VA 22202 |
|-----------------------------------------------|-----------------------------------------------------|

 

 

February 6, 2017

 

RBS Commercial Funding, Inc.as Depositor 

600 Washington Blvd.

Stamford, CT 06901

 

RE:         Annual Statement as to Compliance 

WFRBS 2013 C15

 

Dear Sir/Madam:

 

In accordance with the Poolingand Servicing Agreement entered into in connection with the issuance of theCommercial Mortgage Pass-Through Certificates Series 2013-C15, as an authorizedofficer of National Cooperative Bank, N.A., formerly NCB, FSB (the “Co-opSpecial Servicer”), I hereby certify that:

 

a. A review of the activitiesof the Co-op Special Servicer during the preceding calendar year (the“Reporting Period”) and of its performance under the Pooling andServicing Agreement has been made under my supervision.

 

b. To the best of myknowledge, based on these reviews, the Co-op Special Servicer has fulfilled allobligations under this agreement in all material respects throughout theReporting Period.

 

Please note that the annualfinancial statement will be sent under separate cover on or before March 31,2017.

 

 

Best regards, 

/s/ Karyn Mann

Karyn Mann

Senior Vice President,Investor Compliance 

National Cooperative Bank,N.A.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2336 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 2336

 To amend the Wild and Scenic Rivers Act to designate segments of the 
York River and associated tributaries for study for potential inclusion 
             in the National Wild and Scenic Rivers System.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 23, 2011

   Ms. Pingree of Maine (for herself and Mr. Michaud) introduced the 
    following bill; which was referred to the Committee on Natural 
                               Resources

_______________________________________________________________________

                                 A BILL

 
 To amend the Wild and Scenic Rivers Act to designate segments of the 
York River and associated tributaries for study for potential inclusion 
             in the National Wild and Scenic Rivers System.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``York River Wild and Scenic River 
Study Act of 2011''.

SEC. 2. DESIGNATION FOR STUDY.

    Section 5(a) of the Wild and Scenic Rivers Act (16 U.S.C. 1276(a)) 
is amended by adding at the end the following:
            ``(_) York river, maine.--The York River that flows 11.25 
        miles from its headwaters at York Pond to the mouth of the 
        river at York Harbor, and all associated tributaries.''.

SEC. 3. STUDY AND REPORT.

    Section 5(b) of the Wild and Scenic Rivers Act (16 U.S.C. 1276(b)) 
is amended by adding at the end the following:
            ``(_) The study of the York River, Maine, named in 
        paragraph (__) of subsection (a) shall be completed by the 
        Secretary of the Interior and the report thereon submitted to 
        Congress not later than 3 years after the date on which funds 
        are made available to carry out this paragraph.''.
                                 <all>
```
Exhibit 32.1

 

STATEMENT OF PRINCIPAL EXECUTIVE OFFICER OF AXSOME THERAPEUTICS, INC.PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report of Axsome Therapeutics, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2015 as filed with the Securities and Exchange Commission (the “Report”), I, Herriot Tabuteau, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:

 

1)    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2)    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

| Date: March 24, 2016 | /s/ Herriot Tabuteau, M.D.                                                       |
|----------------------|----------------------------------------------------------------------------------|
|                 | Herriot Tabuteau, M.D.Chief Executive Officer (Principal Executive Officer) |

 

 

----
EX-31 Rule 13a-14(d)/15d-14(d) Certifications.

 

 

I, Helaine M. Kaplan, certify that:

 

1. I have reviewed this report on Form 10-K and all reports on Form 10-D required to be filedin respect of the period covered by this report on Form 10-K of the COMM 2013-CCRE9 Mortgage Trust (the "Exchange Act periodic reports");

 

2. Based on my knowledge, the Exchange Act periodic reports, taken as a whole, do not containany untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, all of the distribution, servicing and other information requiredto be provided under Form 10-D for the period covered by this report is included in the Exchange Act periodic reports;

 

4. Based on my knowledge and the servicer compliance statements required in this report underItem 1123 of Regulation AB, and except as disclosed in the Exchange Act periodic reports, the servicers have fulfilled their obligationsunder the servicing agreements in all material respects; and

 

5. All of the reports on assessment of compliance with servicing criteria for asset-backedsecurities and their related attestation reports on assessment of compliance with servicing criteria for asset-backed securities requiredto be included in this report in accordance with Item 1122 of Regulation AB and Exchange Act Rules 13a-18 and 15d-18 have been includedas an exhibit to this report, except as otherwise disclosed in this report. Any material instances of noncompliance described in suchreports have been disclosed in this report on Form 10-K.

 

In giving the certifications above, I have reasonably relied on information provided to meby the following unaffiliated parties:

 

KeyBank National Association (as successor to KeyCorp Real Estate Capital Markets, Inc.),as Master Servicer, LNR Partners, LLC, as Special Servicer, Midland Loan Services, a Division of PNC Bank, National Association, as SpecialServicer of the Northridge Mall Mortgage Loan, U.S. Bank National Association, as Trustee, and Park Bridge LenderServices LLC, as Operating Advisor.

 

 

 

Dated: March 17,2022

 

 

/s/ Helaine M. Kaplan

 

 

President

(senior officer in charge of securitization of the depositor)
EXHIBIT 4.5


See Legends
on Reverse 


Incorporated Under the Laws of the
State of Delaware


 


 


	*******	*******


 


 


 


 


NOVADEL PHARMA INC.


SERIES A CONVERTIBLE
PREFERRED STOCK $0.001PAR VALUE


 


THIS
IS TO CERTIFY THAT _______________ is the owner of __________(_______)
Shares of the SERIES A CONVERTIBLE PREFERRED STOCK OF 


NOVADEL PHARMA INC.




  transferable only on the books
of the Corporation by the holder hereof, in person or by attorney, upon surrender of this Certificate properly endorsed.


This certificate and the shares
represented hereby are issued and shall have the rights specified in and be held subject to all the provisions of the Certificate
of Incorporation and the Bylaws of said corporation and any amendments thereof, to all of which the holder of this certificate,
by acceptance hereof, assents.


The shares represented by this
Certificate are convertible into shares of Common Stock at the election of the holder thereof and shall be so converted upon the
occurrence of certain events as set forth in the Charter.


The Corporation is authorized to
issue more than one class or series of stock. Upon written request, the Corporation will furnish without charge to each stockholder
a copy of powers, designations, preferences and relative, participating, optional or other special rights of each class of stock
or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights.


IN
WITNESS WHEREOF, the said Corporation has caused this certificate to be signed by its duly authorized officers this _____ day
of _________, 20 ____.


 


	 	 	 	 
	Secretary
	 	President
	 


 



 


 


ANY TRANSFEREE OR ASSIGNEE OF THIS CERTIFICATE SHOULD CAREFULLY
REVIEW THE TERMS OF THE CORPORATION’S CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES A PREFERRED STOCK REPRESENTED
BY THIS CERTIFICATE, INCLUDING SECTION 4(c)(vi) THEREOF. THE NUMBER OF SHARES OF SERIES A PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE
MAY BE LESS THAN THE NUMBER OF SHARES OF SERIES A PREFERRED STOCK STATED ON THE FACE HEREOF PURSUANT TO SECTION 4(c)(vi) OF THE
CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES A PREFERRED STOCK REPRESENTED BY THIS CERTIFICATE.
<PAGE>   1
COMMUNITY CENTRAL BANK CORPORATION
FORM 10-QSB (continued)

                                   EXHIBIT 11
                        COMPUTATION OF PER SHARE EARNINGS


<TABLE>
<CAPTION>
                                                     THREE MONTHS ENDED MARCH 31,
                                                          1999             1998
                                                          ----             ----
                                                      (in thousand, except per share data)
<S>                                                  <C>                  <C>
BASIC

Income (Loss) Before Cumulative Effect
   of Accounting Change                                   $262             ($143)
/ Weighted Average Shares                                2,416             1,531
                                                          ----             ----
   Per Share                                               0.11            (0.09)


Cumulative Effect of Accounting Change                     (57)             ----
/ Weighted Average Shares                                2,416             1,531
                                                          ----              ----
   Per Share                                              (0.02)            ----

                                                          ----              ----

Basic Earnings (Loss) Per Share                           $0.09           ($0.09)
                                                          =====            =====


DILUTED

Income (Loss) Before Cumulative Effect
   of Accounting Change                                   $262             ($143)
/ Weighted Average Shares                                2,424             1,531
                                                          ----              ----
   Per Share                                               0.11            (0.09)


Cumulative Effect of Accounting Change                     (57)             ----
/ Weighted Average Shares                                2,424             1,531
                                                          ----              ----
   Per Share                                              (0.02)            ----

                                                          ----              ----

Diluted Earnings (Loss) Per Share                         $0.09           ($0.09)
                                                          ====             ====
</TABLE>


Notes:
   - Weighted average shares outstanding have been adjusted to reflect the 10%
stock dividends in 1999 and 1998.

   - Where applicable, diluted share computations include the effects of
outstanding stock options.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the NHLBI Special Emphasis Panel.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Heart, Lung, and Blood Institute Special Emphasis Panel; Resources for Clinical Trials.                    

*Date:*                         September 20, 2017.                    

*Time:*                         11:00 a.m. to 1:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6701 Rockledge Drive, Room 7200, Bethesda, MD 20892 (Telephone Conference Call).                    

*Contact Person:*                         Michael P. Reilly, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7200, Bethesda, MD 20892, 301-827-7975,                         *reillymp@nhlbi.nih.gov.*

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: September 1, 2017.

Michelle Trout, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2017-19027 Filed 9-7-17; 8:45 am]

BILLING CODE 4140-01-P
[Federal Register Volume 82, Number 178 (Friday, September 15, 2017)]
[Notices]
[Pages 43413-43414]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19603]


-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Committee on Equal Opportunities in Science and Engineering; 
Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92-
463, as amended), the National Science Foundation (NSF) announces the 
following meeting:
    Name and Committee Code: Committee on Equal Opportunities in 
Science and Engineering (CEOSE) Advisory Committee Meeting (#1173).
    Date and Time: October 12, 2017; 10:00 a.m.-4:00 p.m.
    Place: National Science Foundation, 2415 Eisenhower Avenue, 
Conference Room West 17000, Alexandria, VA 22314.
    Note: CEOSE members will participate virtually. If you are 
interested in attending this meeting, you are required to attend in 
person.
    To help facilitate your entry into the building, please contact 
Illinois Johnson

[[Page 43414]]

(<a href="/cdn-cgi/l/email-protection#87eeede8efe9f4e8e9c7e9f4e1a9e0e8f1"><span class="__cf_email__" data-cfemail="224b484d4a4c514d4c624c51440c454d54">[email protected]</span></a>) on or prior to October 10, 2017.
    Type of Meeting: Open.
    Contact Person: Dr. Bernice Anderson, Senior Advisor and CEOSE 
Executive Secretary, Office of Integrative Activities (OIA), National 
Science Foundation, 2415 Eisenhower Avenue, Alexandria, VA 22314. 
Contact Information: <a href="/cdn-cgi/l/email-protection#3c0b0c0f110e050e11040c080c135e5d5258594e4f537c524f5a125b534a">703-292-8040/<span class="__cf_email__" data-cfemail="83e1e2ede7e6f1f0ecc3edf0e5ade4ecf5">[email protected]</span></a>.
    Minutes: Meeting minutes and other information may be obtained from 
the CEOSE Executive Secretary at the address above or the Web site at 
http://www.nsf.gov/od/oia/activities/ceose/index.jsp.
    Purpose of Meeting: To study data, programs, policies, and other 
information pertinent to the National Science Foundation and to provide 
advice and recommendations concerning broadening participation in 
science and engineering.
    Agenda:
<bullet> Opening Statement and Chair Report by the CEOSE Chair
<bullet> Presentations and Discussions
<bullet> NSF Executive Liaison Report
<bullet> Dissemination of the 2015-2016 Biennial Report to Congress
<bullet> Reports of CEOSE Liaisons to NSF Advisory Committees
<bullet> Updates from the Federal Agency Liaisons
<bullet> Plans for the 2017-2018 Biennial Report to Congress
<bullet> Announcements

    Dated: September 12, 2017.
Crystal Robinson,
Committee Management Officer.
[FR Doc. 2017-19603 Filed 9-14-17; 8:45 am]
 BILLING CODE 7555-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 82, Number 177 (Thursday, September 14, 2017)]
[Notices]
[Page 43237]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19546]


=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Formations of, Acquisitions by, and Mergers of Bank Holding 
Companies

    The companies listed in this notice have applied to the Board for 
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other 
applicable statutes and regulations to become a bank holding company 
and/or to acquire the assets or the ownership of, control of, or the 
power to vote shares of a bank or bank holding company and all of the 
banks and nonbanking companies owned by the bank holding company, 
including the companies listed below.
    The applications listed below, as well as other related filings 
required by the Board, are available for immediate inspection at the 
Federal Reserve Bank indicated. The applications will also be available 
for inspection at the offices of the Board of Governors. Interested 
persons may express their views in writing on the standards enumerated 
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the 
acquisition of a nonbanking company, the review also includes whether 
the acquisition of the nonbanking company complies with the standards 
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, 
nonbanking activities will be conducted throughout the United States.
    Unless otherwise noted, comments regarding each of these 
applications must be received at the Reserve Bank indicated or the 
offices of the Board of Governors not later than October 11, 2017.
    A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant 
Vice President) 230 South LaSalle Street, Chicago, Illinois 60690-1414:
    1. Rigler Investment Company, New Hampton, Iowa; to acquire the 
voting shares of Green Circle Investments, Inc., Clive, Iowa and 
thereby indirectly acquire Peoples Trust and Savings Bank, Clive, Iowa.

    Board of Governors of the Federal Reserve System, September 11, 
2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2017-19546 Filed 9-13-17; 8:45 am]
 BILLING CODE 6210-01-P